Preparatory work is well underway to license an HIV vaccine in South Africa.

If all goes well, in terms of the follow-up trials set to begin in January until 2017, the vaccine could be available for general use by 2019.

The vaccine will be similar to the RV144 vaccine which made headlines across the world in 2009 when it showed that it could protect against HIV infection by up to 31% when tested in Thailand.

The only difference with the vaccine to be tested from next year is that it will have an added protein that will target the HIV strain prevalent in South Africa.
For more http://www.citypress.co.za